Business Combinations and Asset Acquisitions- Narrative (Details) $ / shares in Units, $ in Thousands				1 Months Ended	2 Months Ended	12 Months Ended
	Apr. 12, 2022 USD ($) shares	May 04, 2021 USD ($) $ / shares shares	May 03, 2021 USD ($) shares	Jul. 02, 2021 USD ($) business	Jul. 31, 2021 business	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($)
Business Acquisition [Line Items]
Consideration received on transaction		$ 350,000
Common stock, conversion ratio			1
Shares redeemed								$ 154
Common stock, shares issued (in shares) | shares						132,214,695	150,598,047
Common stock, shares outstanding (in shares) | shares		125,399,913	54,358			132,214,695	150,598,047
Gross consideration received		$ 783,000
Cash acquired from trust account		433,000					$ 433,382
Cash consideration paid to stockholders		368,000					367,870
Payment of transaction costs		$ 57,000					56,976
Legacy HydraFacial shares (in shares) | shares		35,501,743
Reverse Recapitalization, Cash Paid For Working Capital Adjustments		$ 900					902
Working capital adjustment Class A Common Stock issued (in shares) | shares		70,860
Number of acquisitions | business					4
Cash paid for business acquisitions, net of cash acquired						$ 0	22,896	0
Deferred payment for acquisition						4,315	0	0
Cash paid for asset acquisition						$ 1,475	$ 0	$ 0
Mxt
Business Acquisition [Line Items]
Weighted average amortization period	3 years
Cash paid for asset acquisition	$ 1,500
Asset acquisition, equity consideration	$ 500
Asset acquisition, equity consideration (in shares) | shares	28,733
Asset acquisition, contingent consideration (up to)	$ 30,000
Intangible assets acquired	1,900
Inventory acquired	$ 100
HTL, Wigmore, Ecomedic and Sidermica acquisitions
Business Acquisition [Line Items]
Number of acquisitions | business				4
Cash paid for business acquisitions, net of cash acquired				$ 25,700
Deferred payment for acquisition				$ 1,600
HTL, Wigmore, Ecomedic and Sidermica acquisitions | Customer relationships
Business Acquisition [Line Items]
Weighted average amortization period						5 years
HTL, Wigmore, Ecomedic and Sidermica acquisitions | Non-compete agreement
Business Acquisition [Line Items]
Weighted average amortization period						3 years
Class A common stock
Business Acquisition [Line Items]
Consideration received on transaction (in shares) | shares		35,000,000
Stock purchase price (in dollars per share) | $ / shares		$ 10.00
Consideration received on transaction		$ 350,000
Stock redeemed (in shares) | shares		2,672,690
Stock redeemed, price (in dollars per share) | $ / shares		$ 10.00
Shares redeemed		$ 26,700
Common stock, shares issued (in shares) | shares		125,329,053
Common stock, shares outstanding (in shares) | shares		125,329,053
Legacy HydraFacial shares (in shares) | shares		35,501,743
Class B Common Stock
Business Acquisition [Line Items]
Consideration received on transaction (in shares) | shares			11,500,000
Consideration received on transaction			$ 25